Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Elevation Oncology, Inc. - Common stock (NQ: ELEV )

0.5101 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.5101
Bid (Size) 0.4850 (25)
Ask (Size) 0.5200 (1)
Prev. Close 0.5101
Today's Range 0.5101 - 0.5101
52wk Range 0.4146 - 5.830
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Elevation Oncology: Promising Cancer Therapies Earn Analyst Praise
Elevation Oncology's ADCs target CLDN18.2 and HER3, with EO-3021 showing promising Phase 1 results and a $6.6 billion TAM in gastric and pancreatic cancers. 
Via Benzinga
This Denali Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Friday
Via Benzinga

Performance

YTD
-14.28%
-14.28%
1 Month
-18.11%
-18.11%
3 Month
-29.15%
-29.15%
6 Month
-15.48%
-15.48%
1 Year
-87.50%
-87.50%

More News

Read More
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
S&P 500 Surges Over 2%; Caterpillar Earnings Beat Estimates
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
Why Is Penny Stock Elevation Oncology Trading Lower On Tuesday?
Via Benzinga
Recap: Elevation Oncology Q4 Earnings
Via Benzinga
How Is The Market Feeling About Elevation Oncology?
Via Benzinga
Latest Buzz on The Street: Noteworthy Developments at DYAI, ELEV, ATRA, ESPR, KAVL
Via AB Newswire
Crude Oil Moves Higher; Yum! Brands Posts Upbeat Earnings
Via Benzinga
Exposures Fossil Fuels
Dow Jumps Over 300 Points; US Trade Gap Narrows In June
Via Benzinga
Topics Stocks
Exposures US Equities
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing
Via Benzinga
7 Top Stocks to Buy for Under $10: May 2024
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
ELEV Stock Earnings: Elevation Oncology Misses EPS for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
7 Top Stocks Under $7
Via InvestorPlace
5 Healthcare Stocks to Buy for 2024
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
ELEV Stock Earnings: Elevation Oncology Beats EPS for Q4 2023
Via InvestorPlace
Trim the Fat: 3 Overbought Stocks Poised for a Pullback
Via InvestorPlace
3 Stock Winners That Are Up 400% or More in 2024
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Aehr Test Systems Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
Via FinancialNewsMedia
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
From FN Media Group LLC
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.